NIBEC Co. Ltd Total Liabilities

Latest as of June 2026: ₩16.60 Billion KRW ≈ $11.25 Million USD

NIBEC Co. Ltd total liabilities. Based on the latest financial reports, NIBEC Co. Ltd (138610) has total liabilities worth ₩16.60 Billion KRW (≈ $11.25 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 138610 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of NIBEC Co. Ltd (2014–2025)

Total liabilities of NIBEC Co. Ltd from 2014 to 2025. This chart illustrates how NIBEC Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 138610 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

NIBEC Co. Ltd Competitors by Total Liabilities

The table below lists competitors of NIBEC Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Hennessy Capital Investment Corp VI
NASDAQ:HCVI
USA $27.66 Million
Western Carriers India Ltd
NSE:WCIL
India Rs3.38 Billion
SciVision Biotech Inc
TW:1786
Taiwan NT$892.04 Million
ReaLy Development & Construction
TWO:2596
Taiwan NT$3.78 Billion
Supercomnet Technologies Bhd
KLSE:0001
Malaysia RM21.42 Million
The Hi-Tech Gears Limited
NSE:HITECHGEAR
India Rs3.17 Billion
CFI Holding SA
WAR:CFI
Poland zł562.03 Million
Suzhou Shijing Environmental Technology Co.Ltd.
SHE:301030
China CN¥8.60 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down NIBEC Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is NIBEC Co. Ltd's balance sheet.

Liquidity & Leverage Metrics

NIBEC Co. Ltd Total Liabilities Ratios Explained

NIBEC Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.39 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NIBEC Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NIBEC Co. Ltd (2014–2025)

The table below shows the annual total liabilities of NIBEC Co. Ltd from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 ₩17.18 Billion
≈ $11.64 Million
-43.16%
2024-12-31 ₩30.22 Billion
≈ $20.48 Million
-20.38%
2023-12-31 ₩37.96 Billion
≈ $25.72 Million
-1.16%
2022-12-31 ₩38.40 Billion
≈ $26.03 Million
+48.09%
2021-12-31 ₩25.93 Billion
≈ $17.57 Million
+22.09%
2020-12-31 ₩21.24 Billion
≈ $14.39 Million
+154.97%
2019-12-31 ₩8.33 Billion
≈ $5.65 Million
-29.05%
2018-12-31 ₩11.74 Billion
≈ $7.96 Million
-12.30%
2017-12-31 ₩13.39 Billion
≈ $9.07 Million
+1.98%
2016-12-31 ₩13.13 Billion
≈ $8.90 Million
+52.47%
2015-12-31 ₩8.61 Billion
≈ $5.84 Million
-5.06%
2014-12-31 ₩9.07 Billion
≈ $6.15 Million
--

About NIBEC Co. Ltd

KQ:138610 Korea Biotechnology
Market Cap
$102.23 Million
₩150.85 Billion KRW
Market Cap Rank
#18943 Global
#898 in Korea
Share Price
₩13270.00
Change (1 day)
+0.15%
52-Week Range
₩12200.00 - ₩52300.00
All Time High
₩55200.00
About

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more